Author

Paula Layton

Observed name: P. Layton

Institutions: National Institutes of Health, National Cancer Institute

Observed institutions: National Institutes of Health, Duke University, National Cancer Institute, Center for Cancer Research

OpenAlex ID: A5045129801

Dramatic Regression of Chronic Lymphocytic Leukemia in the First Patient Treated With Donor-Derived Genetically-Engineered Anti-CD19-Chimeric-Antigen-Receptor-Expressing T Cells After Allogeneic Hematopoietic Stem Cell Transplantation

2011 · J.N. Kochenderfer, M.E. Dudley, et al. · Transplantation and Cellular Therapy · 10

Adoptive Transfer of Treg-Depleted Donor Th1 and Th2 Cells Safely Accelerates Alloengraftment After Low-Intensity Chemotherapy

2010 · Daniel H. Fowler, Miriam E. Mossoba, et al. · Blood · 3

Allogeneic Hematopoetic Transplantation for CLL: Results of Combination Chemotherapy as Pre-Transplant Targeted Lymphocyte Depletion on Disease Response, Donor Chimerism, and Transplantation Outcomes.

2010 · Brian C Shaffer, Marko Modric, et al. · Blood

Incidence, Risks, and Outcomes of Relapse Following Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma.

2010 · Michael R. Bishop, Seth Steinberg, et al. · Blood

285: Manifestations of acute and chronic graft-versus-host-disease in reduced-intensity allogeneic stem cell transplantation (RISCT) for pediatric cancer

2007 · K. Baird, T.J. Fry, et al. · Transplantation and Cellular Therapy

Early Recovery of Thymus-Derived Naive T Cells in Pediatric Patients (pts) Treated with Non-Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation (NMSCT) for Cancer.

2006 · Terry J. Fry, Alison R. Rager, et al. · Blood

Rapid immune reconstitution and complete donor chimerism after non-myeloablative allogeneic peripheral blood stem cell transplantation (NMSCT) in pediatric patients (PTS) with malignancy

2006 · T.J. Fry, A. Rager, et al. · Transplantation and Cellular Therapy

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (SCT) with Pre-Transplant Targeted Immune Depletion Results in Rapid Full Donor Engraftment in Pediatric Patients with Malignancy.

2005 · Terry J. Fry, Teresa Cardesa-Salzman, et al. · Blood

Works count: 8

Citation count: 13

H-index: 2

I10-index: 1